Bregni, M <br/><br/>
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2006 
 - 311-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705248  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers, Tumor--biosynthesis<br/>Bone Marrow--metabolism<br/>Bone Marrow Neoplasms--metabolism<br/>Bone Marrow Transplantation<br/>Breast Neoplasms--metabolism<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Graft Survival<br/>Graft vs Tumor Effect<br/>Humans<br/>Mammaglobin A<br/>Middle Aged<br/>Myeloablative Agonists--administration & dosage<br/>Neoplasm Proteins--biosynthesis<br/>Predictive Value of Tests<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Thiotepa--administration & dosage<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Uteroglobin--biosynthesis<br/>Vidarabine--administration & dosage